Berlin-based healthcare technology company Recare has successfully raised €37 million in funding, including a €7 million option, to accelerate the rollout of its innovative AI agent designed specifically for hospital discharge management and aftercare coordination. This investment marks a significant milestone for Recare, founded in 2017, as it aims to address critical operational challenges faced by European hospitals, particularly in Germany where it already connects with around two-thirds of all hospitals and over 26,000 care providers.

The AI agent represents a sophisticated software-as-a-service (SaaS) platform that integrates seamlessly with existing hospital IT systems. It automates key administrative processes such as documentation, process control, medical letter generation, and handover protocols. By extracting and structuring data from unstructured sources like PDFs, scans, and free-text entries, the platform coordinates workflows across clinical and administrative teams, significantly reducing the administrative burden on healthcare professionals. This is particularly vital in the context of Europe's looming staffing crisis, with European Commission estimates projecting a shortfall of approximately one million doctors and nurses by 2030.

Recare's CEO, Maximilian Greschke, emphasized the transformative potential of this technology, stating that hospitals are under immense pressure due to increasing administrative tasks that divert time from patient care. The new funding will enable rapid deployment of the AI agent across additional hospitals and care facilities in Germany while paving the way for international expansion. This move aligns with broader digital transformation efforts in European healthcare management, where efficient discharge processes can enhance bed turnover rates, improve patient outcomes, and optimize resource allocation for hospital administrators.

Key investors include DNV, whose Managing Director for Digital Health, Daniel Holth Larsen, highlighted Recare's alignment with priorities around data quality, interoperability, and efficiency in healthcare systems. DNV's involvement underscores the platform's focus on secure, accurate data handling, which is crucial for compliance with stringent European regulations on healthcare IT and patient data protection. The AI agent's ability to orchestrate workflows using unstructured data positions it as a leader in addressing productivity gaps in hospital operations.

For hospital procurement professionals and facility managers, Recare's solution offers measurable benefits in terms of cost savings and operational efficiency. By automating routine tasks, it frees up clinical staff for higher-value activities, directly impacting **Healthcare Management** and **Healthcare Information Technology** categories. The platform's network extends to over 650 rehabilitation clinics, nursing providers, and homecare organizations, creating a comprehensive ecosystem for post-discharge care coordination. This holistic approach is essential for managing patient flow in overburdened systems, reducing readmission rates, and ensuring continuity of care.

As European hospitals grapple with rising costs and workforce shortages, investments like this signal a shift towards AI-driven solutions in **Facilities Management** and patient monitoring workflows. Recare's expansion plans will likely influence strategic partnerships and contracts across the continent, providing decision-makers with tools to enhance resilience. The funding round not only validates the technology's efficacy but also sets a benchmark for future innovations in hospital digital transformation, potentially influencing procurement strategies for medical technology vendors serving the sector.

Looking ahead, Recare's growth trajectory could reshape how hospitals approach discharge protocols, integrating AI to support **Critical Care** transitions and **Emergency Care** handovers. This development is timely, coinciding with broader EU initiatives to bolster healthcare infrastructure through technology. Hospital leaders can anticipate improved interoperability, faster processing times, and data-driven insights that inform resource planning and policy-making at an organizational level. The €37 million infusion ensures sustained R&D, further enhancements, and market penetration, solidifying Recare's role in Europe's evolving healthcare landscape.

In summary, this funding empowers Recare to deliver scalable, AI-powered tools that directly tackle pain points in hospital operations, fostering a more efficient, patient-centered model across Europe.